Abac Therapeutics, SL

Where the EU money came from

Funding by EU programme. Amounts are Abac Therapeutics, SL's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• BREAKthroughPartner

  Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria through existing antibiotics by making their outer membrane permeable

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €14ktheir share
• INNOTARGETSPartner

  Innvative approaches to identification of metabolic Targets for antimicrobials

  Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  €251ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Naicons SRLItaly · 2 shared projects
• Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
• Kobenhavns UniversitetDenmark · 1 shared project
• Stichting VuNetherlands · 1 shared project
• Wageningen UniversityNetherlands · 1 shared project
• Universite Catholique de LouvainBelgium · 1 shared project
• Stichting Amsterdam UmcNetherlands · 1 shared project
• Universitat de BarcelonaSpain · 1 shared project
• University of Newcastle Upon TyneUnited Kingdom · 1 shared project
• Universita Degli Studi di MilanoItaly · 1 shared project
• Univerza V LjubljaniSlovenia · 1 shared project
• Heinrich-Heine-Universitaet DuesseldorfGermany · 1 shared project
• Fundacion Privada Instituto de Salud Global BarcelonaSpain · 1 shared project
• Fundacio Institut Catala D'Investigacio QuimicaSpain · 1 shared project
• Universitat Rovira i VirgiliSpain · 1 shared project
• Institut de Recerca i Tecnologia AgroalimentariesSpain · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• antibiotic resistance
• antibiotics
• bacteriology
• drug discovery
• enzymes
• molecular biology
• multidrug resistance